Task: Answer the MCQ question.
Question: Which drug exhibits a -25.229\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC1CCCC(C)N1CCCNC(=O)c1cc2c(s1)-c1ccccc1OC2
b) Cc1ccc(-c2cc(-c3ccc(C)cc3)[n+](-c3ccccc3)c(-c3ccc(C)cc3)c2)cc1.[O-][Cl+3]([O-])([O-])[O-]
Answer: a. CC1CCCC(C)N1CCCNC(=O)c1cc2c(s1)-c1ccccc1OC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCC(C)N1CCCNC(=O)c1cc2c(s1)-c1ccccc1OC2
CC1CCCC(C)N1CCCNC(=O)c1cc2c(s1)-c1ccccc1OC2
N-[3-(2,6-dimethylpiperidin-1-yl)propyl]-4H-thieno[3,2-c]chromene-2-carboxamide